PICALM and Alzheimer disease: Reduced PICALM expression levels have been reported in cerebral microvessels of AD patients as well as in Picalm+/− mouse model, confirming a central role of PICALM in the exacerbation of Aβ pathology by reducing cerebral Aβ clearance [69,111].